Weighted butterfly optimization algorithm with intuitionistic fuzzy Gaussian function based adaptive-neuro fuzzy inference system for covid-19 prediction
Materials Today: Proceedings, ISSN: 2214-7853, Vol: 56, Page: 3317-3324
2022
- 3Citations
- 25Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Article Description
Covid-19 cases are increasing each day, however none of the countries successfully came up with a proper approved vaccine. Studies suggest that the virus enters the body causing a respiratory infection post contact with a disease. Measures like screening and early diagnosis contribute towards the management of COVID- 19 thereby reducing the load of health care systems. Recent studies have provided promising methods that will be applicable for the current pandemic situation. The previous system designed a various Machine Learning (ML) algorithms such as Decision Tree (DT), Random Forest (RF), XGBoost, Gradient Boosting Machine (GBM) and Support Vector Machine (SVM) for predicting COVID-19 disease with symptoms. However, it does not produce satisfactory results in terms of true positive rate. And also, better optimization methods are required to enhance the precision rate with minimum execution time. To solve this problem the proposed system designed a Weighted Butterfly Optimization Algorithm (WBOA) with Intuitionistic fuzzy Gaussian function based Adaptive-Neuro Fuzzy Inference System (IFGF-ANFIS) classifier for predicting the magnitude of COVID- 19 disease. The principle aim of this method is to design an algorithm that could predict and assess the COVID-19 parameters. Initially, the dataset regarding COVID-19 is taken as an input and preprocessed. The parameters included are age, sex, history of fever, travel history, presence of cough and lung infection. Then the optimal features are selected by using Weighted Butterfly Optimization Algorithm (WBOA) to improve the classification accuracy. Based on the selected features, an Intuitionistic fuzzy Gaussian function based Adaptive-Neuro Fuzzy Inference System (IFGF-ANFIS) classifier is utilized for classifying the people having infection possibility. The studies conducted on this proposed system indicates that it is capable of producing better results than the other systems especially in terms of accuracy, precision, recall and f-measure.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S2214785321066578; http://dx.doi.org/10.1016/j.matpr.2021.10.153; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85146802771&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/34722166; https://linkinghub.elsevier.com/retrieve/pii/S2214785321066578; https://dx.doi.org/10.1016/j.matpr.2021.10.153
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know